SAW
UTHR icon

Signal Advisors Wealth’s United Therapeutics UTHR Stock Holding History

Signal Advisors Wealth’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1,000K Sell
1,845
-182
-9% -$103K 0.05% 276
2026
Q1 		$1.2M Sell
2,027
-21
-1% -$10.5K 0.08% 209
2025
Q4 		$998K Sell
2,048
-547
-21% -$255K 0.08% 198
2025
Q3 		$1.09M Sell
2,595
-2,744
-51% -$923K 0.1% 160
2025
Q2 		$1.53M Buy
+5,339
New +$1.6M 0.12% 163

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Signal Advisors Wealth's UTHR Position: Q2 2026 in Review

Signal Advisors Wealth reduced its United Therapeutics (UTHR) stake by 9% in Q2 2026, selling an estimated $103K and leaving 1,845 shares worth $1,000K. The position accounts for 0.05% of the portfolio, ranked #276.

Signal Advisors Wealth first reported a position in UTHR in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.53M in Q2 2025. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Signal Advisors Wealth held 1,845 shares of United Therapeutics worth $1,000K as of Q2 2026.
  • Signal Advisors Wealth sold 182 United Therapeutics shares in Q2 2026, an estimated $103K.
  • United Therapeutics made up 0.05% of Signal Advisors Wealth's portfolio in Q2 2026, its #276 holding.
  • Signal Advisors Wealth first reported a position in United Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Signal Advisors Wealth's United Therapeutics position peaked at $1.53M in Q2 2025.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Signal Advisors Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.